EIP
MRNA icon

Epoch Investment Partners’s Moderna MRNA Stock Holding History

Epoch Investment Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-211,865
Closed -$25.7M – 438
2023
Q2 		$25.7M Sell
211,865
-283,449
-57% -$37.8M 0.15% 188
2023
Q1 		$76.1M Sell
495,314
-86,992
-15% -$14.4M 0.45% 73
2022
Q4 		$105M Buy
582,306
+250,193
+75% +$40.9M 0.62% 42
2022
Q3 		$39.3M Sell
332,113
-7,344
-2% -$1.11M 0.26% 132
2022
Q2 		$48.5M Buy
+339,457
New +$48.5M 0.28% 122
2021
Q1 		– Sell
-13,992
Closed -$1.46M – 333
2020
Q4 		$1.46M Buy
+13,992
New +$1.42M 0.01% 305
2020
Q2 		– Sell
-76,583
Closed -$2.29M – 298
2020
Q1 		$2.29M Sell
76,583
-161,761
-68% -$3.72M 0.01% 242
2019
Q4 		$4.66M Sell
238,344
-24,314
-9% -$431K 0.02% 244
2019
Q3 		$4.18M Buy
262,658
+34,188
+15% +$505K 0.02% 236
2019
Q2 		$3.35M Buy
+228,470
New +$4.91M 0.02% 249

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Epoch Investment Partners's MRNA Position: Q3 2023 in Review

Epoch Investment Partners sold out of Moderna (MRNA) in Q3 2023, closing a stake of 211,865 shares — an estimated $25.7M sold.

Epoch Investment Partners first reported a position in MRNA in Q2 2019 and held it in 10 quarters. The position peaked at $105M in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Epoch Investment Partners reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Epoch Investment Partners sold 211,865 Moderna shares in Q3 2023, an estimated $25.7M.
  • Epoch Investment Partners first reported a position in Moderna in Q2 2019 and held it in 10 quarters.
  • Epoch Investment Partners's Moderna position peaked at $105M in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Epoch Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.